Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FUdR/Leucovorin With Oxaliplatin and Docetaxel in Metastatic Gastric Adenocarcinoma
NCT00448682Phase 2Terminated
- Sponsor
- University of Miami
- Start
- Jun 2005
- Primary completion
- Dec 2009
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of floxuridine, folinic acid, oxaliplatin, docetaxel in gastric adenocarcinoma, sponsored by University of Miami. Started Jun 2005; status: terminated.
02
Drugs
floxuridinefolinic acidoxaliplatindocetaxel
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT00448682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00448682.